Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media
Study Identifier
M01-352
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
CSR.ORG
Sex
Female & Male
Age
6 Months - 4 Years
Protocol Summary
To evaluate the safety and efficacy of cefdinir oral suspension in children between 6 months
and 4 years of age, with acute otitis media, who are at risk of persistent or recurrent
otitis media.
Study Locations
Location
Status
Location
Scottsdale, Arizona, United States, 85258
Status
Not applicable
Location
Clovis, California, United States, 93611
Status
Not applicable
Location
Dinuba, California, United States, 93618
Status
Not applicable
Location
Folsom, California, United States, 95630
Status
Not applicable
Location
Denver, Colorado, United States, 80218
Status
Not applicable
Location
Brooklyn, New York, United States, 11203
Status
Not applicable
Showing {first} - {last} of {total} Results